I Kedar

628 total citations
23 papers, 487 citations indexed

About

I Kedar is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, I Kedar has authored 23 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Immunology. Recurrent topics in I Kedar's work include Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers), Alzheimer's disease research and treatments (3 papers) and Ovarian cancer diagnosis and treatment (2 papers). I Kedar is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers), Alzheimer's disease research and treatments (3 papers) and Ovarian cancer diagnosis and treatment (2 papers). I Kedar collaborates with scholars based in Israel, United States and Germany. I Kedar's co-authors include M Ravid, E Sohar, Mordchai Ravid, J. Shapira, P. Sathiyamoorthy, Jacob Gopas, Yaakov Pollack, Avi Golan‐Goldhirsh, R Lang and J Gafni and has published in prestigious journals such as The Lancet, The Journal of Immunology and Annals of the New York Academy of Sciences.

In The Last Decade

I Kedar

22 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
I Kedar Israel	15	222	68	63	61	54	23	487
Irena Kustrzeba−Wójcicka Poland	14	209 0.9×	43 0.6×	120 1.9×	51 0.8×	83 1.5×	32	627
Terumi Takahashi Japan	16	220 1.0×	33 0.5×	74 1.2×	126 2.1×	84 1.6×	43	783
Soo Young Moon South Korea	15	240 1.1×	48 0.7×	77 1.2×	47 0.8×	64 1.2×	52	788
Inna P. Gladysheva United States	16	259 1.2×	46 0.7×	58 0.9×	45 0.7×	46 0.9×	52	810
Cynthia Shackelford United States	7	137 0.6×	37 0.5×	39 0.6×	61 1.0×	54 1.0×	11	516
Tasuku Yamada Japan	14	294 1.3×	64 0.9×	14 0.2×	62 1.0×	79 1.5×	38	839
Ting‐Hui Lin Taiwan	13	238 1.1×	27 0.4×	49 0.8×	60 1.0×	40 0.7×	32	552
K. F. McGeeney Ireland	15	251 1.1×	90 1.3×	110 1.7×	31 0.5×	320 5.9×	53	767
Moon‐Jin Jeong South Korea	11	237 1.1×	41 0.6×	72 1.1×	35 0.6×	37 0.7×	55	532
Wenguang Wang China	15	279 1.3×	67 1.0×	57 0.9×	48 0.8×	103 1.9×	55	653

Countries citing papers authored by I Kedar

Since Specialization

Citations

This map shows the geographic impact of I Kedar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Kedar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Kedar more than expected).

Fields of papers citing papers by I Kedar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I Kedar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Kedar. The network helps show where I Kedar may publish in the future.

Co-authorship network of co-authors of I Kedar

This figure shows the co-authorship network connecting the top 25 collaborators of I Kedar. A scholar is included among the top collaborators of I Kedar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I Kedar. I Kedar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kedar, I, et al.. (2004). Thalidomide reduces serum C‐reactive protein and interleukin‐6 and induces response to IL‐2 in a fraction of metastatic renal cell cancer patients who failed IL‐2‐based therapy. International Journal of Cancer. 110(2). 260–265. 20 indexed citations

Ben-Aroya, Zahi, Elena Zelin, Mordechai Hallak, et al.. (2001). Activation of HTLV-I Long Terminal Repeat by Stress-Inducing Agents and Protection of HTLV-I-Infected T-cells from Apoptosis by the Viral Tax Protein. Experimental Cell Research. 271(1). 169–179. 32 indexed citations

Ariad, Samuel, Shmuel Argov, Esther Manor, Tikva Yermiahu, & I Kedar. (2000). Acute Blast Crisis with EBV-Infected Blasts, in a Patient with Chronic Myeloid Leukemia, and Vasculitis. Leukemia & lymphoma. 37(3-4). 431–435.

Sathiyamoorthy, P., et al.. (1999). Screening for Cytotoxic and Antimalarial Activities in Desert Plants of the Negev and Bedouin Market Plant Products. Pharmaceutical Biology. 37(3). 188–195. 97 indexed citations

Piura, Benjamin, Mihai Meirovitz, & I Kedar. (1998). Long-term disease-free survival following surgery and active specific immunotherapy with allogeneic vaccine in a patient with high-risk malignant melanoma of the vulva. European Journal of Obstetrics & Gynecology and Reproductive Biology. 81(1). 83–85. 5 indexed citations

Piura, Benjamin, I Kedar, Samuel Ariad, Mihai Meirovitz, & Ilana Yanai‐Inbar. (1998). Malignant Melanoma Metastatic to the Ovary. Gynecologic Oncology. 68(2). 201–205. 15 indexed citations

Urba, Walter J., Luise Hartmann, Dan L. Longo, et al.. (1990). Phase I and immunomodulatory study of a muramyl peptide, muramyl tripeptide phosphatidylethanolamine.. PubMed. 50(10). 2979–86. 38 indexed citations

Kedar, I & Alfred D. Steinberg. (1987). Functional diversity of Ia epitopes on macrophages. European Journal of Immunology. 17(7). 915–919. 1 indexed citations

Lishner, Michael, Ruth Lang, I Kedar, & Mordchai Ravid. (1985). Treatment of Diabetic Perforating Ulcers (Mal Perforant) with Local Dimethylsulfoxide. Journal of the American Geriatrics Society. 33(1). 41–43. 18 indexed citations

10.

Ravid, M, et al.. (1985). Ascorbic acid-induced regression of amyloidosis in experimental animals.. PubMed. 66(2). 137–41. 4 indexed citations

11.

Ravid, M, J. Shapira, R Lang, & I Kedar. (1982). Prolonged dimethylsulphoxide treatment in 13 patients with systemic amyloidosis.. Annals of the Rheumatic Diseases. 41(6). 587–592. 46 indexed citations

12.

Kedar, I, E Sohar, & M Ravid. (1982). Degradation of amyloid by a serum component and inhibition of degradation.. PubMed. 99(5). 693–700. 21 indexed citations

13.

Kedar, I & E Sohar. (1981). Dimethyl sulfoxide in experimental atherosclerosis of the rabbit.. PubMed. 17(4). 289–91. 4 indexed citations

14.

Kedar, I, et al.. (1981). Alleviation of Experimental Ischemic Acute Renal Failure by Dimethyl Sulfoxide. The Nephron journals/Nephron journals. 29(1-2). 55–58. 27 indexed citations

15.

Ravid, M, et al.. (1979). Regression of amyloidosis secondary to granulomatous ileitis following surgical resection and colchicine administration.. PubMed. 26(6). 513–5. 21 indexed citations

16.

Ravid, Mordchai, I Kedar, & E Sohar. (1977). EFFECT OF A SINGLE DOSE OF DIMETHYL SULPHOXIDE ON RENAL AMYLOIDOSIS. The Lancet. 309(8014). 730–731. 27 indexed citations

17.

Kedar, I, M Ravid, & E Sohar. (1976). In vitro synthesis of "amyloid"fibrils from insulin, calcitonin and parathormone.. PubMed. 12(10). 1137–40. 14 indexed citations

18.

Kedar, I, Ilan Bleiberg, & E Sohar. (1975). Stimulation of murine amyloidosis by a dializable product from pretreated donors.. PubMed. 56(3). 244–6. 4 indexed citations

19.

Kedar, I, M Ravid, & E Sohar. (1974). PAS-bisulfite stain for diabetic angiopathy. Beiträge zur Pathologie. 151(3). 322–326. 1 indexed citations

20.

Kedar, I, M Ravid, E Sohar, & J Gafni. (1974). Colchicine inhibition of casein-induced amyloidosis in mice.. PubMed. 10(7). 787–9. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact